Balyasny Asset Management
GHSI

Balyasny Asset Management’s Guardion Health Sciences, Inc. Common Stock GHSI Stock Holding History

Balyasny Asset Management’s Portfolio GHSI Stock Details GHSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-897
Closed -$6K – 3329
2022
Q3 		$6K Buy
+897
New +$6.84K ﹤0.01% 2696

Other funds holding GHSI

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Balyasny Asset Management's GHSI Position: Q4 2022 in Review

Balyasny Asset Management sold out of Guardion Health Sciences, Inc. Common Stock (GHSI) in Q4 2022, closing a stake of 897 shares — an estimated $6K sold.

Balyasny Asset Management first reported a position in GHSI in Q3 2022 and held it in 1 quarter. The position peaked at $6K in Q3 2022. 22 funds tracked by Wall St. Rank hold GHSI as of Q4 2022.

  • Balyasny Asset Management reported no remaining Guardion Health Sciences, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Balyasny Asset Management sold 897 Guardion Health Sciences, Inc. Common Stock shares in Q4 2022, an estimated $6K.
  • Balyasny Asset Management first reported a position in Guardion Health Sciences, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Balyasny Asset Management's Guardion Health Sciences, Inc. Common Stock position peaked at $6K in Q3 2022.
  • 22 funds tracked by Wall St. Rank held Guardion Health Sciences, Inc. Common Stock as of Q4 2022.

Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.